Rapid Aneurysm is an FDA-cleared imaging platform for cerebral aneurysm management. Helping physicians save time, improve patient care, and increase patient volume by accelerating the process of finding, tracking and proactively treating aneurysms. With Rapid Aneurysm, physicians across multiple disciplines and referral networks can more effectively identify and prioritize patients.
“A well-validated AI programme [Rapid Aneurysm] that detects cerebral aneurysms is expected to be an asset to radiologists. AI programmes that detect cerebral aneurysms on CTA have been shown to improve radiologists’ sensitivity for the detection of aneurysms.”
"Artificial intelligence aneurysm measurement tool [Rapid Aneurysm] finds growth in all aneurysms that ruptured during conservative management."